Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors
- PMID: 19767206
- PMCID: PMC2792201
- DOI: 10.1016/j.bmcl.2009.08.092
Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors
Abstract
There is strong interest to study the involvement of brain cannabinoid subtype-1 (CB1) receptors in neuropsychiatric disorders with single photon emission computed tomography (SPECT) and a suitable radioligand. Here we report the synthesis of a novel high-affinity radioiodinated CB1 receptor ligand ([125I]8, [125I]1-(2-iodophenyl)-4-cyano-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxylate, [125I]SD7015). By autoradiography in vitro, [125I]8 showed selective binding to CB1 receptors on human brain postmortem cryosections and now merits labeling with iodine-123 for further evaluation as a SPECT radioligand in non-human primate.
Figures
References
-
- Lambert DM. J Pharm Belg. 2001;56:111. - PubMed
-
- Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Mol Pharmacology. 1988;34:605. - PubMed
-
- Munro S, Thomas KL, Abushaar M. Nature. 1993;365:61. - PubMed
-
- Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. Pharmacol Rev. 2002;54:161. - PubMed
-
- Van Laere K. Eur J Nucl Med Mol Imaging. 2007;34:1719. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
